UCSF experts outline new strategy to eliminate malaria
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
University of California San Francisco
Give to UCSFUCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
UCSF has captured the excitement of the two-day groundbreaking festivities for UCSF Medical Center at Mission Bay in a new video now posted online.
New technologies and techniques continue to accelerate the pace of discovery in human genetics research, a fact made clear by scientists who spoke about their searches for important mutations, gene variants and answers to basic biological questions at the UCSF Institute for Human Genetics’ fifth-anniversary symposium on Oct. 28.
<em>The Lancet</em> launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.
The UCSF Challenge for the Children, a collaboration with the online fundraising platform Causes.com, kicks off today (Oct. 26, 2010) as part of the groundbreaking festivities for the new UCSF Medical Center at Mission Bay, site of the future children’s hospital as well as women’s and cancer hospitals.
The National Institutes of Health (NIH) on September 30 announced 52 highly competitive awards for high-risk, high-payoff research for young biomedical scientists, and UCSF tops California institutions with four recipients.
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
Genentech scientist Napoleone Ferrara, who has just been named the winner of a Lasker Award, is being recognized for his noteworthy achievements made when he was a postdoc at UCSF.
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
A UCSF-led team has discovered at least one key reason why blood stem cells are susceptible to developing the genetic mutations that can lead to adult leukemia.
A UCSF-led team has discovered a direct link between an inherited genetic mutation, a set of developmental abnormalities and a rare form of childhood leukemia called juvenile myelomonocytic leukemia, or JMML.
Harold Varmus, MD, who was a UCSF faculty member for more than two decades, was sworn into office on Monday, July 12, as the new director of the National Cancer Institute (NCI), one of the National Institutes of Health (NIH).
James McKerrow, leader of the Sandler Center for Drug Discovery at UCSF, was honored with the 2009 Mendel Medal for his work identifying the vulnerabilities of disease-causing parasites and for devising new strategies to fight them.
It is well-known that vitamin D is essential for strong and healthy bones. However, in an article in the online “In Press” section of “Trends in Endocrinology and Metabolism,” a San Francisco VA Medical Center physician reviews recent scientific literature suggesting that the vitamin may also play a role in preventing cancer, fighting infection, and controlling or preventing auto-immune disease.